BeStock  
Stocks › Medical Devices › BBNX

Beta Bionics BBNX

US equityMarket cap rank #3360Medical Devices
$13.36 +$0.04 (+0.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.36 0.00%
Open$13.05
Prev close$13.32
Day range$12.92 – $13.85
Volume960.3K
Market cap$726.34M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership128.9%-2.53 pts vs. prior quarter
Institutions holding189+14 vs. prior quarter
Insider trades (recent)13 buys / 37 sellsNet selling
Short interest9.16% of floatDays to cover 3.9 · as of 30 Oct 2026
Short-sale volume share19.1%5-day average of daily volume

Short-sale volume as % of daily volume

6%17%28%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$955.1K (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$52.0KSuper−$903.1KBig−$857.3KMid−$605.5KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 50.8% of shares outstanding.

Largest holders

  • T. Rowe Price Group, Inc.16.45%
  • Eventide Asset Management, LLC11.50%
  • Morgan Stanley Investment Management Inc.7.97%
  • Morgan Stanley7.97%
  • Soleus Capital Management, L.P.6.96%
  • Sands Capital Alternatives, LLC6.82%
  • Sands Capital Management, LLC6.57%
  • BlackRock6.28%

By investor type

  • Mutual Fund67.29%
  • Hedge Fund35.72%
  • VC/PE Fund12.62%
  • Public Company11.58%
  • Individual/Insider2.01%
  • Government Pension Fund0.80%
  • Sovereign Wealth Fund0.36%
  • Private Company0.29%

Reported short interest has fallen from 16.66% to 9.16% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +8,899,611 16.4%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +826,477 2.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +456,629 4.1%
FMR Mutual Fund 2026/Q3 +437,623 0.8%
TD Asset Management Mutual Fund 2026/Q3 +392,422 0.7%
JPMorgan Chase & Co. Public Company 2026/Q3 +345,160 0.8%
ING Groep N.V. Public Company 2026/Q3 +250,000 0.5%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +190,175 0.3%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +179,556 0.3%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +167,503 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +86,314 0.2%
Divisadero Street Capital Management, LP Hedge Fund 2026/Q3 +1,959,183 5.7%
Tri Locum Partners LP Hedge Fund 2026/Q3 +493,344 0.9%
Bank of America Corporation Public Company 2026/Q3 +427,742 1.0%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +415,426 1.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Nov 2026 Stephen Feider Chief Financial Officer Derivative Exercise and Sale -8,874 $17.21 159,378
8 Nov 2026 Stephen Feider Chief Financial Officer Derivative Exercise and Sale -744 $17.00 159,378
4 Nov 2026 Stephen Feider Chief Financial Officer Derivative Exercise and Sale -382 $17.04 159,378
1 Nov 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -370 $16.90 54,143
26 Oct 2026 Mike Mensinger Chief Product Officer Automatic Disposition -2,650 $22.00 174,740
25 Oct 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -821 $20.00 54,513
13 Oct 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -775 $17.35 55,334
30 Sep 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -370 $18.96 56,109
21 Sep 2026 Christina Jones Independent Director Automatic Disposition -6,430 $23.00 4,842
15 Sep 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -30,779 $20.13 56,479
15 Sep 2026 Mike Mensinger Chief Product Officer Automatic Disposition -2,650 $22.00 177,390
13 Sep 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -775 $15.52 86,382
8 Sep 2026 Mark Hopman Chief Commercial Officer Open Market Disposition -35,994 $18.46 88,033
2 Sep 2026 Sean Saint Chief Executive Officer Automatic Disposition -5,641 $20.08 398,429
1 Sep 2026 Sean Saint Chief Executive Officer Open Market Disposition -16,867 $19.11 404,070
1 Sep 2026 Stephen Feider Chief Financial Officer Open Market Disposition -6,675 $19.11 159,378
1 Sep 2026 Steven Russell Chief Medical Officer Open Market Disposition -4,221 $19.11 169,628
1 Sep 2026 Mark Hopman Chief Commercial Officer Open Market Disposition -5,327 $19.11 124,027
1 Sep 2026 Mike Mensinger Chief Product Officer Open Market Disposition -4,375 $19.11 180,040
28 Jun 2026 Stephen Feider Chief Financial Officer Derivative Exercise and Sale -10,000 $17.05 166,053

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,980,771 9.2% 3.9
15 Oct 2026 6,917,021 15.4% 7.4
30 Sep 2026 6,046,389 13.4% 3.3
15 Sep 2026 10,617,768 23.6% 9.9
31 Aug 2026 9,400,691 20.9% 9.0
14 Aug 2026 7,494,706 16.7% 5.5

Discussion

No comments yet — be the first to weigh in on BBNX.

Sign in to join the discussion.

Scroll to Top